For the quarter ending 2025-12-31, COR had -$2,585,856K decrease in cash & cash equivalents over the period. -$2,424,545K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net income | 566,126 | -333,071 | 689,749 | 717,417 |
| Depreciation, including amounts charged to cost of goods sold | 135,247 | 133,728 | 130,356 | 123,597 |
| Amortization, including amounts charged to interest expense | 129,024 | 130,270 | 128,617 | 140,376 |
| Provision for credit losses | 13 | 17,792 | 33,159 | 8,484 |
| Provision (benefit) for deferred income taxes | 14,362 | 55,389 | -16,658 | 26,210 |
| Share-based compensation expense | 66,054 | 25,943 | 23,184 | 28,452 |
| Lifo credit | -77,562 | -56,962 | -52,058 | 39,469 |
| Trkiye highly inflationary impact | 8,723 | 12,660 | 16,799 | 18,394 |
| Impairment of assets, including goodwill | 249,498 | 837,378 | - | - |
| Adjustments-Contingent Consideration Equity Units | - | 121,666 | - | - |
| Adjustments to rca equity units | -32,783 | - | 37,460 | 37,460 |
| Adjustments-Contingent Consideration Predefined Business Objective | - | 19,550 | - | - |
| Loss on divestiture of businesses | 0 | 0 | 0 | 0 |
| Gain on remeasurement of equity investment | 10,501 | -16,501 | 27,259 | -180 |
| Gain on divestiture of equity investment | - | 0 | 12,838 | - |
| Gain on sale of assets | 35,816 | - | - | - |
| Other, net | -6,726 | 3,594 | 39,768 | -2,767 |
| Accounts receivable | 830,752 | 945,803 | 759,565 | -756,213 |
| Inventories | 3,519,839 | 319,548 | 984,133 | -1,689,417 |
| Prepaid expenses and other assets | 14,386 | 63,957 | -143,541 | -23,963 |
| Accounts payable | 1,307,868 | 3,755,256 | 607,587 | -15,314 |
| Accrued expenses | -328,365 | 295,519 | 172,820 | -489,470 |
| Income taxes payable and other liabilities | -13,726 | -86,278 | 18,254 | -94,507 |
| Long-term accrued litigation liability | - | -404,102 | 0 | 0 |
| Net cash used in operating activities | -2,305,169 | 3,133,417 | 109,247 | 3,351,238 |
| Capital expenditures | 119,376 | 249,812 | 183,216 | 129,060 |
| Cost of acquired companies, net of cash acquired | 219,686 | 91,410 | 56,459 | 3,938,746 |
| Proceeds from sale of assets | 43,057 | - | - | - |
| Cost of equity investments | 10,710 | 2,450 | 1,216 | 10,562 |
| Non-customer note receivable | 0 | 0 | 0 | 0 |
| Other, net | -7,400 | -21,732 | -6,200 | -745 |
| Net cash used in investing activities | -299,315 | -321,940 | -234,691 | -4,077,623 |
| Loan and senior notes borrowings | 107,720 | 0 | 1,187,808 | 3,320,674 |
| Loan repayments | 131,709 | 517,203 | 756,143 | 1,244,773 |
| Borrowings under revolving and securitization credit facilities | 23,791,590 | 45,980,788 | 42,521,709 | 28,177,470 |
| Repayments under revolving and securitization credit facilities | 23,501,389 | 46,045,822 | 43,172,266 | 29,521,240 |
| Purchases of common stock | 0 | 0 | 0 | 50,000 |
| Exercises of stock options | 7,598 | 6,520 | 6,835 | 7,670 |
| Cash dividends on common stock | 126,516 | 107,512 | 107,493 | 111,188 |
| Employee tax withholdings related to restricted share vesting | 98,151 | 109 | 116 | 3,595 |
| Other, net | -5,939 | -444 | -6,146 | -1,886 |
| Net cash provided by financing activities | 43,204 | -683,782 | 215,484 | -491,738 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | -24,576 | -8,472 | 6,720 | 1,715 |
| (decrease) increase in cash, cash equivalents, and restricted cash | -2,585,856 | 2,119,223 | 96,760 | -1,216,408 |
| Cash and cash equivalents at beginning of period | 4,394,549 | 2,275,326 | 2,178,566 | 3,394,974 |
| Cash and cash equivalents at end of period | 1,808,693 | 4,394,549 | 2,275,326 | 2,178,566 |
Cencora, Inc. (COR)
Cencora, Inc. (COR)